Treatments After Progression on FOLFOXIRI Bevacizumab
Treatments After Progression on FOLFOXIRI Bevacizumab
2021年3月18日
medscape.com
Lonsurf/Bevacizumab for Advanced Metastatic Colorectal Cancer
Lonsurf/Bevacizumab for Advanced Metastatic Colorectal Cancer
2024年2月12日
medscape.com
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Tumor Treating Field Therapy in Combination with Bevacizumab for t…
2014年10月27日
jove.com
Bevacizumab In Combination Therapy For Patients With a Driver Mutation
Bevacizumab In Combination Therapy For Patients With a Driver Mutation
2019年5月2日
medscape.com
Combination Therapy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel for Metastatic Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Resistance and EGFR Mutations - Watch Related Videos
Combination Therapy of Atezolizumab, Bevacizumab, Carboplatin, and Pacli…
2 个月之前
jove.com
No Benefit to Extending Bevacizumab in Ovarian Cancer
No Benefit to Extending Bevacizumab in Ovarian Cancer
2023年10月16日
medscape.com
Considerations for Use of Bevacizumab-vikg in Wet AMD | AJMC
Considerations for Use of Bevacizumab-vikg in Wet AMD | AJMC
2022年3月16日
ajmc.com
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment o…
2 个月之前
jove.com
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for …
2012年3月2日
jove.com
AVADO Trial Confirms Bevacizumab Benefit
2008年6月2日
medscape.com
Targeted Therapy for Cancer
2022年5月31日
cancer.gov
2:50
Eli Lilly to release single-dose vials of Zepbound to improve access
2024年8月27日
TODAY.com
Outlook Therapeutics, Inc.: Outlook Therapeutics Announces NICE Reco…
2024年4月12日
finanznachrichten.de
Cofepris autoriza el registro sanitario a medicamento para tratar diversos tip…
2025年1月8日
eleconomista.com.mx
Junshi Biosciences Announces Approval of sNDA for Toripalimab in …
2025年3月23日
thespec.com
Efficacy of Locoregional Treatment for Oligo-Drug-Resistant Lesions during …
1 个月前
jove.com
Outlook Therapeutics, Inc.: Outlook Therapeutics Announces SMC Reco…
5 个月之前
finanznachrichten.de
Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Cape…
2 个月之前
jove.com
Immune Checkpoint Inhibitors
2022年4月7日
cancer.gov
Targeted Therapy
2023年5月3日
cancer.org
BioDlink's Bevacizumab Approved for Market Launch in Nigeria, Accelerati…
9 个月之前
kron4.com
2025重症肌无力指南发布！IMC及MC（IVb型-V型）治疗有讲究，科学 …
7 个月之前
qq.com
BREAKWATER Phase III: results for encorafenib and cetuximab plus mF…
3 个月之前
nih.gov
Innovazioni terapeutiche per l’epatocarcinoma: il potere della com…
6 个月之前
tuobenessere.it
Cervical cancer - Diagnosis and treatment - Mayo Clinic
8 个月之前
mayoclinic.org
Sandoz, Bio-Thera Reach Deal On Biosimilar Bevacizumab For Treatme…
2021年9月8日
nasdaq.com
Intravitreal bevacizumab in macular edema secondary to branch retinal v…
2024年12月25日
nih.gov
La Cofepris autoriza el registro sanitario a medicamento para tratar …
2025年1月8日
eleconomista.com.mx
In Vitro Physicochemical and Pharmacokinetic Properties of Bevac…
2 个月之前
jove.com
观看更多视频
静态缩略图占位符